Discovery provides therapeutic target for amyotrophic lateral sclerosis

Researchers have found that the ability of a protein made by a gene called FUS to bind to RNA is essential to the development of amyotrophic lateral sclerosis (ALS). This discovery identifies a possible therapeutic target for the fatal neurological disease.

Read the whole article on Science Daily

More from Science Daily